Plain-English translation of NCT04419272 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Epilepsy research guide →Phase 4 — The treatment has already been approved. Researchers are tracking how it works in a large number of people over time.
This trial is testing whether a medication called — a prescription stimulant that helps with focus and attention — can help people with epilepsy who struggle with concentration and memory. Researchers want to see if this medication improves thinking and quality of life compared to a placebo (sugar pill), and whether it's safe for people taking seizure medications.
Many people with epilepsy experience problems with attention, memory, and thinking — sometimes from the seizures themselves or the medications used to treat them. This trial is designed to find out if this medication could help improve these cognitive problems and give people better quality of life.
You likely qualify if…
You likely don't qualify if…
If you're accepted into the study, you'll be randomly assigned to receive either the medication or a placebo (sugar pill) twice daily for 8 weeks — you won't know which one you're getting. During this time, you'll complete thinking and memory tests at the start, at week 8, and at week 16. After the first 8 weeks, everyone gets the chance to try the real medication for another 8 weeks. You'll also fill out a survey about your quality of life. Throughout the study, researchers will monitor whether your seizures change and check that the treatment is safe for you.
AI-generated summary from trial data · Jun 13, 2026 · Not medical advice
United States